[go: up one dir, main page]

CN103992486B - Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel - Google Patents

Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel Download PDF

Info

Publication number
CN103992486B
CN103992486B CN201410167756.5A CN201410167756A CN103992486B CN 103992486 B CN103992486 B CN 103992486B CN 201410167756 A CN201410167756 A CN 201410167756A CN 103992486 B CN103992486 B CN 103992486B
Authority
CN
China
Prior art keywords
polypeptide
tetrazolium
light
tetrazole
hydrogel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201410167756.5A
Other languages
Chinese (zh)
Other versions
CN103992486A (en
Inventor
夏建飞
赵凯
王宗花
蔡峰
张菲菲
夏霖
迟德玲
李延辉
夏延致
夏临华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao University
Original Assignee
Qingdao University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao University filed Critical Qingdao University
Priority to CN201410167756.5A priority Critical patent/CN103992486B/en
Publication of CN103992486A publication Critical patent/CN103992486A/en
Application granted granted Critical
Publication of CN103992486B publication Critical patent/CN103992486B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Peptides Or Proteins (AREA)

Abstract

本发明公开了一种光控四唑-烯点击化学合成多肽水凝胶的制备方法,步骤包括:1)具有特定氨基酸序列的多肽和功能性四唑按照投料比为1:(2,4,6,8,10)混合,通过酯化反应将四唑连接到多肽分子上;2)得到的多肽四唑衍生物与端基修饰甲基丙烯基团的双链DNA按照摩尔比1:(2,3,4)在pH7.4、37℃条件下混合,波长300~400nm的紫外灯照射100~200s,引发四唑-烯反应,迅速交联形成凝胶;本发明的有益效果为:水凝胶在制备的过程中具有时空可控性,无须光引发剂和铜盐等催化剂,得到了荧光性能的多肽水凝胶,具有很强的示踪性,双链DNA分子中的核酸适体有靶向功能,在生物医学和靶向治疗等领域有着潜在的应用价值。

The invention discloses a method for preparing polypeptide hydrogels synthesized by light-controlled tetrazole-ene click chemistry. 6,8,10) mixing, tetrazole is connected on the polypeptide molecule by esterification; 2) The double-stranded DNA of the obtained polypeptide tetrazole derivative and the end group modified methacrylic group is according to molar ratio 1:(2 , 3, 4) mixed under conditions of pH 7.4 and 37°C, and irradiated with an ultraviolet lamp with a wavelength of 300-400nm for 100-200s to trigger a tetrazole-ene reaction and rapidly cross-link to form a gel; the beneficial effects of the present invention are: water The preparation process of the gel has space-time controllability, without catalysts such as photoinitiators and copper salts, a fluorescent polypeptide hydrogel is obtained, which has strong traceability, and nucleic acid aptamers in double-stranded DNA molecules It has a targeting function and has potential application value in the fields of biomedicine and targeted therapy.

Description

光控四唑-烯点击化学合成多肽水凝胶的制备方法Preparation method of peptide hydrogel synthesized by light-controlled tetrazole-ene click chemistry

技术领域technical field

本发明涉及一种多肽水凝胶的制备方法,尤其涉及一种光控四唑-烯点击化学合成多肽水凝胶的制备方法。The invention relates to a method for preparing polypeptide hydrogel, in particular to a method for preparing polypeptide hydrogel synthesized by light-controlled tetrazole-ene click chemistry.

背景技术Background technique

水凝胶是一种以水为分散介质的凝胶,具有三维网络立体结构,具有对环境刺激的敏感性、高溶胀性、渗透性及与人体组织的相似性,负载能力较高,可以实现对药物的高效包载;这些特性使得水凝胶在组织工程、药物运载和靶向治疗中得到了广泛的应用。目前,用于制备水凝胶的方法主要为物理交联法和化学交联法,其中。物理交联包括憎水作用、聚乳酸的立体复合作用、静电作用等,化学交联方法形成水凝胶的典型反应有:酶交联反应、自由基聚合反应、希夫碱反应、双硫键反应、迈克尔加成反应等。Hydrogel is a kind of gel with water as the dispersion medium. It has a three-dimensional network structure. It has sensitivity to environmental stimuli, high swelling, permeability and similarity to human tissue. It has a high load capacity and can realize Efficient entrapment of drugs; these characteristics make hydrogels widely used in tissue engineering, drug delivery and targeted therapy. At present, the methods used to prepare hydrogels are mainly physical cross-linking methods and chemical cross-linking methods, among which. Physical crosslinking includes hydrophobic interaction, stereocomplexation of polylactic acid, electrostatic interaction, etc. Typical reactions of chemical crosslinking methods to form hydrogels include: enzyme crosslinking reaction, free radical polymerization reaction, Schiff base reaction, disulfide bond reaction, Michael addition reaction, etc.

多肽是一种天然的生物大分子。基于多肽的水凝胶完全降解后的产物只有氨基酸,因此在人体内不会产生不良影响,也不会引起机体的不良反应以及一些组织炎症,使得多肽在开发创新医药学技术方面发挥越来越重要的作用,如药物的控释技术、细胞治疗新支架的研究、组织工程等。而且,多肽水凝胶具有良好的生物相容性,它能为细胞的分布和细胞外基质的积累提供支架,并且这些具有生物适应性和生物降解性的支架,在组织修复和组织工程中有着十分广泛的应用。目前,多肽水凝胶的制备方法主要有自组装法和化学交联法,其中,自组装法多用于注射性的多肽水凝胶,授权公告号为CN102408575B的中国发明专利公开了通过超声震荡法助溶,将离子补偿性多肽溶于浓度为3~20mM的NaCl水溶液中,再由所得溶液通过自组装得到可注射多肽水凝胶;化学交联法包括酶催化交联法和点击化学法,其中授权公告号为CN102688525B的中国发明专利公开了一种酶催化交联法制备的多肽水凝胶,Macromolecules,2012,45,9579-9584中描述了一种点击化学法制备的多肽水凝胶。上述制备多肽水凝胶的方法存在一定的不足之处:(1)多肽的自组装水凝胶之间都是通过较弱的分子间非共价作用结合,这使得水凝胶的机械性能较差,很容易被破坏;(2)酶催化交联可能会会引发毒性和免疫反应;(3)传统的点击化学合成多肽水凝胶过程中加入了铜催化剂,其存在可能会诱导病毒或寡核苷酸的降解,并且具有细胞毒性;而无铜点击化学的方法制得的多肽水凝胶通常受限于凝胶时间较长且储存模量较低。Peptides are natural biological macromolecules. The products of complete degradation of peptide-based hydrogels are only amino acids, so they will not have adverse effects in the human body, nor will they cause adverse reactions in the body and some tissue inflammation, making peptides play an increasingly important role in the development of innovative medical technologies. Important roles, such as controlled release technology of drugs, research on new scaffolds for cell therapy, tissue engineering, etc. Moreover, polypeptide hydrogels have good biocompatibility, which can provide scaffolds for the distribution of cells and the accumulation of extracellular matrix, and these biocompatible and biodegradable scaffolds have great potential in tissue repair and tissue engineering. Very wide range of applications. At present, the preparation methods of polypeptide hydrogel mainly include self-assembly method and chemical cross-linking method. Among them, the self-assembly method is mostly used for injectable polypeptide hydrogel. The Chinese invention patent with the authorized notification number CN102408575B discloses Solubilization, the ion-compensating polypeptide is dissolved in a NaCl aqueous solution with a concentration of 3-20mM, and then the resulting solution is self-assembled to obtain an injectable polypeptide hydrogel; chemical cross-linking methods include enzyme-catalyzed cross-linking and click chemistry. Among them, the Chinese invention patent with the authorized announcement number CN102688525B discloses a polypeptide hydrogel prepared by an enzyme-catalyzed cross-linking method, and Macromolecules, 2012, 45, 9579-9584 describes a polypeptide hydrogel prepared by a click chemistry method. There are certain deficiencies in the above-mentioned method for preparing polypeptide hydrogels: (1) the self-assembled hydrogels of polypeptides are all combined by weaker intermolecular non-covalent interactions, which makes the mechanical properties of hydrogels relatively weak. (2) Enzyme-catalyzed cross-linking may cause toxicity and immune reactions; (3) Copper catalysts are added to the traditional click chemical synthesis of polypeptide hydrogels, and their presence may induce viruses or oligosaccharides. Nucleotide degradation and cytotoxicity; while polypeptide hydrogels prepared by copper-free click chemistry are usually limited by longer gel time and lower storage modulus.

发明内容Contents of the invention

针对上述现有技术,本发明提供了一种光控四唑-烯点击化学合成多肽水凝胶的制备方法,该方法中水凝胶在制备的过程中具有时空可控性,既保留了传统的“点击化学”快速高效、专一性和反应条件温和的特点,又无须光引发剂和铜盐等催化剂,且得到的多肽水凝胶具有荧光性,便于观察,适用于药物载体、生物医学以及药物释放等领域。Aiming at the above-mentioned prior art, the present invention provides a method for preparing polypeptide hydrogels synthesized by light-controlled tetrazole-ene click chemistry. The "click chemistry" has the characteristics of rapidity, high efficiency, specificity and mild reaction conditions, and does not require catalysts such as photoinitiators and copper salts, and the obtained polypeptide hydrogel is fluorescent and easy to observe. It is suitable for drug carriers, biomedical and drug release.

本发明是通过以下技术方案实现的:The present invention is achieved through the following technical solutions:

一种光控四唑-烯点击化学合成多肽水凝胶的制备方法,包括以下步骤:多肽四唑衍生物的合成:A method for preparing polypeptide hydrogels synthesized by light-controlled tetrazole-ene click chemistry, comprising the following steps: Synthesis of polypeptide tetrazole derivatives:

(1)在氮气的保护下,向50mL两颈瓶中加入0.2~0.4g四唑,二氯甲烷15~20ml搅拌至溶解,得到四唑的二氯甲烷溶液;(1) Under the protection of nitrogen, add 0.2 to 0.4 g of tetrazole to a 50 mL two-necked bottle, and stir 15 to 20 ml of dichloromethane until dissolved to obtain a dichloromethane solution of tetrazole;

(2)向四唑的二氯甲烷溶液中加入DCC(N,N-二环己基碳二亚胺)150~200mg继续搅拌15~20min,得到四唑溶液;(2) Add 150-200 mg of DCC (N,N-dicyclohexylcarbodiimide) to the dichloromethane solution of tetrazole and continue stirring for 15-20 minutes to obtain a tetrazole solution;

(3)将多肽溶于5~10mL二氯甲烷中,得多肽溶液,其中,多肽的氨基酸序列为ThrSerThrSerThrSerThrSerThrSerThrSer,且每个氨基酸中均含有一个侧链羟基,将上述多肽溶液加入到步骤(2)所得的四唑溶液中,搅拌15~20min;向多肽与四唑的混合液中加入10~15mg DMAP(4-二甲氨基吡啶),反应10~12h,过滤,滤液用冰乙醚沉淀,干燥后得到多肽分子的四唑衍生物;(3) Dissolve the polypeptide in 5-10mL of dichloromethane to obtain a polypeptide solution, wherein the amino acid sequence of the polypeptide is ThrSerThrSerThrSerThrSerThrSerThrSer, and each amino acid contains a side chain hydroxyl group, and the above polypeptide solution is added to step (2) Stir in the obtained tetrazole solution for 15-20 minutes; add 10-15 mg DMAP (4-dimethylaminopyridine) to the mixture of polypeptide and tetrazole, react for 10-12 hours, filter, and precipitate the filtrate with ice ether, dry Obtaining tetrazole derivatives of polypeptide molecules;

多肽水凝胶的光控点击合成:Light-controlled click synthesis of peptide hydrogels:

(4)分别将步骤(3)所得多肽四唑衍生物和端基修饰烯丙基的双链DNA溶于Tris-HCl缓冲液中,至完全溶解,其中多肽与DNA的摩尔比为1:2~1:4;(4) Dissolve the polypeptide tetrazole derivative obtained in step (3) and the allyl-modified double-stranded DNA in Tris-HCl buffer until completely dissolved, wherein the molar ratio of polypeptide to DNA is 1:2 ~1:4;

(5)将步骤(4)所得混合液在37℃下混合均匀后,于真空条件下,置于波长300~400nm的紫外灯下,光照100~200s,引发四唑-烯点击化学反应,迅速交联形成具有荧光性能的多肽水凝胶。(5) After mixing the mixed solution obtained in step (4) at 37°C, place it under a UV lamp with a wavelength of 300-400nm under vacuum conditions, and illuminate it for 100-200s to trigger the tetrazole-ene click chemical reaction, and quickly Cross-linking forms a polypeptide hydrogel with fluorescent properties.

优选地,步骤(3)所述选多肽与四唑的摩尔比为1:6。Preferably, the molar ratio of the selected polypeptide to tetrazole in step (3) is 1:6.

所述双链DNA中的一条为核酸适体链。One of the double-stranded DNAs is a nucleic acid aptamer strand.

所述核酸适体链为AS1411适体或sgc8适体。The nucleic acid aptamer chain is AS1411 aptamer or sgc8 aptamer.

优选地,步骤(4)所述多肽与DNA的摩尔比为1:3。Preferably, the molar ratio of polypeptide to DNA in step (4) is 1:3.

步骤(4)所述Tris-HCl缓冲液的pH7.4,含10mM NaCl。The pH7.4 of Tris-HCl damping solution described in step (4), contains 10mM NaCl.

优选地,步骤(5)所述紫外光波长为375nm。Preferably, the wavelength of the ultraviolet light in step (5) is 375nm.

优选地,步骤(5)所述光照时间为180s。Preferably, the illumination time in step (5) is 180s.

本发明还提供一种利用上述方法制备的一种光控四唑-烯点击化学合成多肽水凝胶。The present invention also provides a light-controlled tetrazole-ene click chemically synthesized polypeptide hydrogel prepared by the above method.

本发明通过简单的酯化反应将功能性的四唑小分子连接到多肽分子上得到四唑衍生物;然后,多肽与DNA的混合溶液通过紫外光照射引发四唑-烯反应迅速交联形成水凝胶,具有以下优点:The present invention connects functional small molecules of tetrazole to polypeptide molecules through a simple esterification reaction to obtain tetrazole derivatives; then, the mixed solution of polypeptide and DNA is irradiated by ultraviolet light to trigger tetrazole-ene reaction to rapidly cross-link to form water gel, which has the following advantages:

1、多肽水凝胶在合成的过程中,时间和空间具有可控性;1. During the synthesis process of polypeptide hydrogel, time and space are controllable;

2、多肽水凝胶在合成的过程中利用了光控点击化学反应,反应条件温和,无须铜盐催化剂;2. In the synthesis process of polypeptide hydrogel, light-controlled click chemical reaction is used, the reaction conditions are mild, and copper salt catalyst is not required;

3、多肽水凝胶在光控合成过程中,无须光引发剂,直接由紫外照射引发反应;3. In the process of light-controlled synthesis of polypeptide hydrogel, no photoinitiator is needed, and the reaction is directly initiated by ultraviolet irradiation;

4、制备的多肽水凝胶有很强的荧光性能,具有很强的示踪性;4. The prepared polypeptide hydrogel has strong fluorescence properties and strong traceability;

5、得到的多肽水凝胶中的核酸适体链可以实现对癌细胞的靶向功能。5. The nucleic acid aptamer chain in the obtained polypeptide hydrogel can realize the targeting function to cancer cells.

附图说明Description of drawings

图1为光控四唑-烯点击合成的反应示意图;Figure 1 is a schematic diagram of the photo-controlled tetrazole-ene click synthesis reaction;

图2为多肽的四唑衍生物的合成示意图;Fig. 2 is the synthesizing schematic diagram of the tetrazole derivative of polypeptide;

图3为光控四唑-烯点击合成多肽水凝胶的示意图;Fig. 3 is a schematic diagram of light-controlled tetrazole-ene click synthesis polypeptide hydrogel;

其中,1.多肽的四唑衍生物,2.端基修饰烯丙基的DNA,其中一条链为核酸适体链,另一条链为其互补链,3.水凝胶。Among them, 1. Tetrazole derivatives of polypeptides, 2. DNA with allyl groups modified at the end groups, one of which is a nucleic acid aptamer chain, and the other chain is its complementary chain, 3. Hydrogel.

图4为图案化水凝胶的合成示意图;Figure 4 is a schematic diagram of the synthesis of patterned hydrogels;

图5为载药水凝胶对癌细胞的靶向释药示意图;Figure 5 is a schematic diagram of drug-loaded hydrogel targeted drug release to cancer cells;

其中,1.抗癌药物,2.核酸适体,3.受体,4.细胞膜,5.细胞核,6.氨基酸小分子。Among them, 1. Anticancer drugs, 2. Nucleic acid aptamers, 3. Receptors, 4. Cell membranes, 5. Cell nuclei, 6. Amino acid small molecules.

具体实施方式Detailed ways

下面结合实施例对本发明作进一步的说明。The present invention will be further described below in conjunction with embodiment.

实施例1:Example 1:

一种光控四唑-烯点击化学合成多肽水凝胶的制备方法,包括以下步骤:A preparation method for light-controlled tetrazole-ene click chemical synthesis of polypeptide hydrogel, comprising the following steps:

多肽四唑衍生物的合成,如图2所示:The synthesis of polypeptide tetrazole derivatives is shown in Figure 2:

(1)在氮气的保护下,向50mL两颈瓶中加入0.4g四唑,二氯甲烷20ml搅拌至溶解;(1) Under the protection of nitrogen, add 0.4g tetrazole to a 50mL two-necked bottle, and stir 20ml of dichloromethane until dissolved;

(2)向四唑溶液中加入DCC(N,N-二环己基碳二亚胺)150mg继续搅拌15min;(2) Add 150 mg of DCC (N,N-dicyclohexylcarbodiimide) to the tetrazole solution and continue stirring for 15 minutes;

(3)具有特定氨基酸序列的多肽分子ThrSerThrSerThrSerThrSerThrSerThrSer,如SEQ IDNO.1所示,溶于5mL二氯甲烷中,得多肽溶液,将上述多肽溶液加入四唑溶液中,其中,多肽与四唑的摩尔比为1:6,搅拌15min;向多肽与四唑的混合液中加入12mg DMAP(4-二甲氨基吡啶),反应12h,过滤,滤液用冰乙醚沉淀,干燥后得到多肽分子的四唑衍生物;(3) The polypeptide molecule ThrSerThrSerThrSerThrSerThrSerThrSer with a specific amino acid sequence, as shown in SEQ ID NO.1, is dissolved in 5mL of dichloromethane to obtain a polypeptide solution, and the above polypeptide solution is added to the tetrazole solution, wherein the molar amount of the polypeptide and tetrazole The ratio is 1:6, stirring for 15 minutes; adding 12 mg DMAP (4-dimethylaminopyridine) to the mixture of polypeptide and tetrazole, reacting for 12 hours, filtering, and the filtrate is precipitated with glacial ether, and dried to obtain the tetrazole derivative of the polypeptide molecule. thing;

多肽水凝胶的光控点击合成,如图1、3和4所示:Light-controlled click synthesis of polypeptide hydrogels, as shown in Figures 1, 3 and 4:

(4)分别将步骤(3)所得多肽四唑衍生物和端基修饰烯丙基的双链DNA溶于300μLTris-HCl缓冲液(pH7.4,10mM NaCl)中,至完全溶解,其中多肽与DNA的摩尔比为1:3;(4) Dissolve the double-stranded DNA of the polypeptide tetrazole derivative and the end-group modified allyl group obtained in step (3) in 300 μL Tris-HCl buffer solution (pH 7.4, 10 mM NaCl) until completely dissolved, wherein the polypeptide and The molar ratio of DNA is 1:3;

(5)将步骤(4)所得混合液在37℃下混合均匀后,于真空条件下,以带有图案的光掩模板遮盖,置于波长375nm的紫外灯下,光照180s,引发四唑-烯点击化学反应,迅速交联形成图案化的水凝胶,在倒置荧光显微镜下可以观察到图案化的荧光凝胶,说明多肽水凝胶的合成具有时空可控性。(5) Mix the mixture obtained in step (4) uniformly at 37°C, cover it with a photomask with a pattern under vacuum, place it under a UV lamp with a wavelength of 375nm, and illuminate it for 180s to induce tetrazole- The ene click chemical reaction quickly cross-linked to form a patterned hydrogel, and the patterned fluorescent gel can be observed under an inverted fluorescence microscope, indicating that the synthesis of polypeptide hydrogels is controllable in time and space.

所述双链DNA中的一条为核酸适体链。One of the double-stranded DNAs is a nucleic acid aptamer strand.

所述核酸适体链为AS1411适体。The nucleic acid aptamer chain is AS1411 aptamer.

实施例2:Example 2:

一种光控四唑-烯点击化学合成多肽水凝胶的制备方法,包括以下步骤:A preparation method for light-controlled tetrazole-ene click chemical synthesis of polypeptide hydrogel, comprising the following steps:

多肽四唑衍生物的合成:Synthesis of Polypeptide Tetrazole Derivatives:

(1)在氮气的保护下,向50mL两颈瓶中加入0.2g四唑,二氯甲烷15ml搅拌至溶解;(1) Under the protection of nitrogen, add 0.2g tetrazole to a 50mL two-necked bottle, and stir 15ml of dichloromethane until dissolved;

(2)向四唑溶液中加入DCC(N,N-二环己基碳二亚胺)200mg继续搅拌20min;(2) Add 200 mg of DCC (N,N-dicyclohexylcarbodiimide) to the tetrazole solution and continue stirring for 20 minutes;

(3)具有特定氨基酸序列的多肽分子ThrSerThrSerThrSerThrSerThrSerThrSer,溶于10mL二氯甲烷中,得多肽溶液,将上述多肽溶液加入四唑溶液中,其中,多肽与四唑的摩尔比为1:8,搅拌20min;向多肽与四唑的混合液中加入15mg DMAP(4-二甲氨基吡啶),反应12h,过滤,滤液用冰乙醚沉淀,干燥后得到多肽分子的四唑衍生物;(3) The polypeptide molecule ThrSerThrSerThrSerThrSerThrSerThrSer with a specific amino acid sequence is dissolved in 10 mL of dichloromethane to obtain a polypeptide solution, and the above polypeptide solution is added to the tetrazole solution, wherein the molar ratio of the polypeptide to tetrazole is 1:8, and stirred for 20 minutes ; Add 15mg DMAP (4-dimethylaminopyridine) to the mixed solution of polypeptide and tetrazole, react for 12h, filter, and the filtrate is precipitated with glacial ether, and the tetrazole derivative of polypeptide molecule is obtained after drying;

多肽水凝胶的光控点击合成:Light-controlled click synthesis of peptide hydrogels:

(4)分别将步骤(3)所得多肽四唑衍生物和端基修饰烯丙基的双链DNA溶于300μLTris-HCl缓冲液(pH7.4,10mM NaCl)中,至完全溶解,其中多肽与DNA的摩尔比为1:4;(4) Dissolve the double-stranded DNA of the polypeptide tetrazole derivative and the end-group modified allyl group obtained in step (3) in 300 μL Tris-HCl buffer solution (pH 7.4, 10 mM NaCl) until completely dissolved, wherein the polypeptide and The molar ratio of DNA is 1:4;

(5)将步骤(4)所得混合液在37℃下混合均匀后,于真空条件下,置于波长350nm的紫外灯下,光照200s,引发四唑-烯点击化学反应,迅速交联形成水凝胶。(5) Mix the mixture obtained in step (4) evenly at 37°C, place it under a UV lamp with a wavelength of 350nm under vacuum conditions, and illuminate it for 200s to trigger a tetrazole-ene click chemical reaction and rapidly cross-link to form water gel.

所述双链DNA中的一条为核酸适体链。One of the double-stranded DNAs is a nucleic acid aptamer strand.

所述核酸适体链为sgc8适体。The nucleic acid aptamer chain is sgc8 aptamer.

实施例3:Example 3:

一种光控四唑-烯点击化学合成多肽水凝胶的制备方法,包括以下步骤:A preparation method for light-controlled tetrazole-ene click chemical synthesis of polypeptide hydrogel, comprising the following steps:

多肽四唑衍生物的合成:Synthesis of Polypeptide Tetrazole Derivatives:

(1)在氮气的保护下,向50mL两颈瓶中加入0.3g四唑,二氯甲烷18ml搅拌至溶解;(1) Under the protection of nitrogen, add 0.3g of tetrazole to a 50mL two-necked bottle, and stir 18ml of dichloromethane until dissolved;

(2)向四唑溶液中加入DCC(N,N-二环己基碳二亚胺)175mg继续搅拌18min;(2) Add 175 mg of DCC (N,N-dicyclohexylcarbodiimide) to the tetrazole solution and continue stirring for 18 minutes;

(3)具有特定氨基酸序列的多肽分子ThrSerThrSerThrSerThrSerThrSerThrSer,溶于7mL二氯甲烷中,得多肽溶液,将上述多肽溶液加入四唑溶液中,其中,多肽与四唑的摩尔比为1:4,搅拌17min;向多肽与四唑的混合液中加入10mg DMAP(4-二甲氨基吡啶),反应10h,过滤,滤液用冰乙醚沉淀,干燥后得到多肽分子的四唑衍生物;(3) The polypeptide molecule ThrSerThrSerThrSerThrSerThrSerThrSer with a specific amino acid sequence was dissolved in 7mL of dichloromethane to obtain a polypeptide solution, and the above polypeptide solution was added to the tetrazole solution, wherein the molar ratio of polypeptide to tetrazole was 1:4, and stirred for 17min Add 10mg DMAP (4-dimethylaminopyridine) to the mixed solution of polypeptide and tetrazole, react for 10h, filter, and the filtrate is precipitated with glacial ether, and the tetrazole derivative of polypeptide molecule is obtained after drying;

多肽水凝胶的光控点击合成:Light-controlled click synthesis of peptide hydrogels:

(4)将多肽四唑衍生物、端基修饰烯丙基的双链DNA和阿霉素溶于300μL pH7.4,含10mMNaCl的Tris-HCl缓冲液中至完全溶解,得混合液,其中多肽四唑衍生物、DNA和阿霉素的摩尔比为1:3:3;(4) Polypeptide tetrazole derivatives, double-stranded DNA modified with allyl groups at the end groups, and doxorubicin were dissolved in 300 μL of Tris-HCl buffer solution containing 10 mM NaCl at pH 7.4 until completely dissolved to obtain a mixture, in which the peptide The molar ratio of tetrazole derivatives, DNA and doxorubicin is 1:3:3;

(5)将步骤(4)所得混合液在37℃下混合均匀后,于真空条件下,置于波长375nm的紫外灯下,光照180s,引发四唑-烯点击化学反应,迅速交联,形成包载阿霉素的水凝胶。(5) After mixing the mixture obtained in step (4) evenly at 37°C, place it under a UV lamp with a wavelength of 375nm under vacuum conditions, and illuminate it for 180s to trigger a tetrazole-ene click chemical reaction, which rapidly cross-links and forms Hydrogels loaded with doxorubicin.

所述双链DNA中的一条为核酸适体链。One of the double-stranded DNAs is a nucleic acid aptamer strand.

所述核酸适体链为AS1411适体。The nucleic acid aptamer chain is AS1411 aptamer.

如图5所示,收集对数期细胞和癌细胞,调整细胞悬液浓度,每孔加入100ul细胞悬液,铺板使待测细胞调密度至1000-10000孔(边缘孔用无菌Tris填充);在5%CO2,37℃孵育,至细胞单层铺满孔底(96孔平底板),细胞贴壁后,于次日将上述本发明实施例3制备的包载阿霉素的水凝胶加入相应的孔中,设7个梯度,每孔100ul,设5个复孔;然后在5%CO2,37℃孵育24~72小时;每孔加入20uL5mg/mL3-(4,5-二甲基噻唑-2)-2,5-二苯基四氮唑溴盐(MTT)溶液,继续培养4h,终止培养,小心吸去孔内培养液;每孔加入150uL二甲基亚砜,置摇床上低速振荡10min,使结晶物充分溶解,在酶联免疫检测仪OD570nm处测量各孔的吸光值。As shown in Figure 5, collect the logarithmic phase cells and cancer cells, adjust the concentration of the cell suspension, add 100ul of the cell suspension to each well, and plate to adjust the density of the cells to be tested to 1000-10000 wells (the edge wells are filled with sterile Tris) ; incubate at 5% CO 2 at 37°C until the cell monolayer covers the bottom of the well (96-well flat-bottomed plate). Add the gel into corresponding wells, set up 7 gradients, 100ul per well, and set up 5 duplicate wells; then incubate at 5% CO 2 at 37°C for 24-72 hours; add 20uL 5mg/mL3-(4,5- Dimethylthiazole-2)-2,5-diphenyltetrazolium bromide (MTT) solution, continue to cultivate for 4 hours, terminate the culture, carefully suck off the culture medium in the well; add 150uL dimethyl sulfoxide to each well, Shake on a shaker at a low speed for 10 minutes to fully dissolve the crystals, and measure the absorbance of each well at OD570nm in an enzyme-linked immunosorbent detector.

结果显示,正常细胞存活率达到100%左右,随着培养时间的延长细胞也能够正常的增殖,说明该水凝胶没有细胞毒性;癌细胞的存活率明显减少,只有10%,说明该水凝胶能够很好地实现靶向释药,并且能够有效抑制癌细胞的增殖,杀死癌细胞。The results show that the survival rate of normal cells reaches about 100%, and the cells can proliferate normally with the prolongation of culture time, indicating that the hydrogel has no cytotoxicity; the survival rate of cancer cells is significantly reduced, only 10%, indicating that the hydrogel has no cytotoxicity. The glue can well realize targeted drug release, and can effectively inhibit the proliferation of cancer cells and kill cancer cells.

上述虽然结合附图对本发明的具体实施方式进行了描述,但并非对本发明保护范围的限制,所属领域技术人员应该明白,在本发明的技术方案的基础上,本领域技术人员不需要付出创造性劳动即可做出的各种修改或变形仍在本发明的保护范围以内。Although the specific implementation of the present invention has been described above in conjunction with the accompanying drawings, it does not limit the protection scope of the present invention. Those skilled in the art should understand that on the basis of the technical solution of the present invention, those skilled in the art do not need to pay creative work Various modifications or variations that can be made are still within the protection scope of the present invention.

Claims (9)

1. the preparation method of light-operated tetrazolium-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, comprise the following steps:
The synthesis of polypeptide terazole derivatives:
(1) under the protection of nitrogen, in 50mL two neck bottle, add 0.2 ~ 0.4g tetrazolium, methylene dichloride 15 ~ 20ml is stirred to dissolving, obtains the dichloromethane solution of tetrazolium;
(2) in the dichloromethane solution of tetrazolium, add N, N-dicyclohexylcarbodiimide 150 ~ 200mg continues stirring 15 ~ 20min, obtains tetrazolium solution;
(3) polypeptide is dissolved in 5 ~ 10mL methylene dichloride, obtain polypeptide solution, wherein, the aminoacid sequence of polypeptide is ThrSerThrSerThrSerThrSerThrSerThrSer, aforementioned polypeptides solution is joined in the tetrazolium solution of step (2) gained, stir 15 ~ 20min; In the mixed solution of polypeptide and tetrazolium, add 10 ~ 15mg DMAP, reaction 10 ~ 12h, filter, filtrate uses ice ether sedimentation, obtains the terazole derivatives of peptide molecule after drying;
The light-operated click synthesis of polypeptide hydrogel:
(4) respectively step (3) gained polypeptide terazole derivatives and end group being modified allylic double-stranded DNA is dissolved in Tris-HCl damping fluid, and to dissolving completely, wherein the mol ratio of polypeptide and DNA is 1:2 ~ 1:4;
(5) after step (4) gained mixed solution being mixed at 37 DEG C, under vacuum condition, under being placed in the ultraviolet lamp of wavelength 300 ~ 400nm, illumination 100 ~ 200s, cause tetrazolium-alkene clicking chemistry reaction, be cross-linked to form rapidly the polypeptide hydrogel with fluorescence property.
2. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, the mol ratio of step (3) described polypeptide and tetrazolium is 1:6.
3. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, one in described double-stranded DNA is aptamer chain.
4. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, described aptamer chain is that AS1411 is fit or sgc8 is fit.
5. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, the mol ratio of step (4) described polypeptide and DNA is 1:3.
6. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, the pH7.4 of the described Tris-HCl damping fluid of step (4), containing 10mM NaCl.
7. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, step (5) described ultraviolet wavelength is 375nm.
8. the preparation method of light-operated tetrazolium as claimed in claim 1-alkene clicking chemistry improvement on synthesis hydrogel, is characterized in that, step (5) described light application time is 180s.
9. the light-operated tetrazolium of one-alkene clicking chemistry improvement on synthesis hydrogel prepared by the method described in any one of claim 1-8.
CN201410167756.5A 2014-04-24 2014-04-24 Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel Active CN103992486B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410167756.5A CN103992486B (en) 2014-04-24 2014-04-24 Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410167756.5A CN103992486B (en) 2014-04-24 2014-04-24 Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel

Publications (2)

Publication Number Publication Date
CN103992486A CN103992486A (en) 2014-08-20
CN103992486B true CN103992486B (en) 2015-06-10

Family

ID=51306844

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410167756.5A Active CN103992486B (en) 2014-04-24 2014-04-24 Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel

Country Status (1)

Country Link
CN (1) CN103992486B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101912826B1 (en) * 2016-10-25 2018-10-30 한국생산기술연구원 Hydrogels having specific molecular affinity and method for controling hydrogels volume using the same
CN115976655A (en) * 2023-03-20 2023-04-18 深圳市小分子新药创新中心有限公司 Method for synthesizing On-DNA hydrazide compound and DNA coding compound library

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101864178A (en) * 2010-06-17 2010-10-20 复旦大学 A kind of injectable chemically cross-linked protein/polypeptide hydrogel and its preparation method
US20120202263A1 (en) * 2011-02-03 2012-08-09 The Trustees Of The University Of Pennsylvania Bioactive Macromers and Hydrogels and Methods for Producing Same
CN102408575B (en) * 2011-09-09 2013-02-13 南京大学 Preparation method of injectable polypeptide hydrogel
CN102688525B (en) * 2012-05-07 2013-11-27 东南大学 A kind of biomacromolecule hydrogel and preparation method thereof
CN103396554B (en) * 2013-07-02 2015-04-29 苏州大学 Hydrogel, preparation method thereof and applications

Also Published As

Publication number Publication date
CN103992486A (en) 2014-08-20

Similar Documents

Publication Publication Date Title
Yan et al. Small interfering RNA-loaded chitosan hydrochloride/carboxymethyl chitosan nanoparticles for ultrasound-triggered release to hamper colorectal cancer growth in vitro
CN105816920B (en) A kind of preparation method of modified sodium alginate embolism microball
CN111848975B (en) Phosphorylated protein, intracellular delivery system based on phosphorylated protein, preparation method and application
CN107550921A (en) Double medicine-carried systems of a kind of nano particle macromolecule injectable composite aquogel and preparation method thereof
CN109355310B (en) ROS (reactive oxygen species) -responsive gene delivery vector as well as preparation method and application thereof
CN105482105B (en) A kind of degradable main chain quaternary polycation and preparation method thereof
CN106046382A (en) Nitric oxide loaded cationic polymer, preparation method therefor and application of nitric oxide loaded cationic polymer
CN101716346B (en) A kind of supramolecular hydrogel gene carrier material and its preparation method and application
WO2019214219A1 (en) Method for preparing ph/reduction responsive polyamino acid zwitterionic nanoparticles
CN106890343B (en) Targeting polypeptide nano gene vector compound
CN105218699A (en) The chitosan of oligomerization arginine covalent modification, preparation method, screening and application
Bondalapati et al. Rapid end‐group modification of polysaccharides for biomaterial applications in regenerative medicine
CN109745567A (en) Preparation and application of a DNA-immobilized nano-hydrogel microsphere and its complex with nucleic acid aptamers
KR101112756B1 (en) Photoreactive Chitosan Derivatives and Their Uses
CN104146946B (en) A kind of graphene oxide medicine carrying composite of hepatoma-targeting and preparation method thereof
CN101812178A (en) Reduction sensitive polyethyleneimine derivative as well as preparation method and application thereof
CN104311830B (en) Dendritic gene and drug carrier, and preparation and application thereof
CN103992486B (en) Click chemical-synthesis preparation method of light-operated tetrazole-alkene for polypeptide hydrogel
CN103990143A (en) Liver cancer-targeted multi-walled carbon nanotube drug-loaded composite material and preparation method thereof
CN101974154B (en) Modified polyethyleneimine and preparation method thereof
Asokan-Sheeja et al. In Situ Synthesis and Self-Assembly of Peptide–PEG Conjugates: A Facile Method for the Construction of Fibrous Hydrogels
CN104306983A (en) Redox-sensitive hyaluronic acid-docetaxel conjugate and preparation method thereof
CN106749517B (en) Polysaccharide derivative containing polypeptide targeting factor and preparation method thereof
CN111138682A (en) Fluorescence-labeled biological material and preparation method thereof
CN103497961B (en) A kind of gene vector system and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant